News and Conferences
1
-
OARSI 2024
Read moreHosted in Vienna, Austria between April 18th-21st -
Western Veterinary Conference
Read moreLas Vegas, USA -
AD/PD 2024
Read moreLisbon, Portugal -
Animal Health, Nutrition & Technology Innovation
Read moreLondon, UK -
VMX 2024
Read moreOrlando, Florida -
American College of Toxicology
Read more44th Annual Meeting of ACT. -
Society for Neuroscience 2023
Read moreWe will be attending SfN 2023 located in the USA capital, Washington DC this year between 11th-15th November 2023 -
CNS Summit
Read moreCNS Summit was founded in 2009 by leaders in the life sciences as a community to advance the work of life sciences companies with a focus on innovation, collaboration and technology. -
Canine Conference 2023
Read moreTranspharmation is proud to sponsor Canine Conference 2023, being held in Niagara-on-the-Lake, Canada, from November 1-3. The Canine Conference brings together leaders of companion animal experts from around the world, representing both industry and academia. -
Animal Health, Nutrition & Technology Innovation - Asia
Read moreAnimal Health, Nutrition & Technology Innovation - Asia focuses on advancing innovation, product regulation and strategic corporate partnerships in Asia Pacific.
1
Want to see our latest study results?
Sign up for our newsletter.
Newsletters
- Natural and induced models of osteoarthritis in Beagle dogs 2024-04-30
- Utilizing Rapid Screening Tests to Assess the Antidepressant Potential of Psychedelic Analogues 2024-04-16
- Long-term antidepressant effect of ketamine and psilocybin in the Chronic Social Defeat stress model 2024-03-21
- Diabetes and Metabolic Syndrome 2024-03-14
- Transpharmation's Animal Health Services 2024-02-29
- Longevity Research Goes to the Dogs 2024-02-20
- Transpharmation's Cutting-Edge Antiepileptic Drug Screening: A Global Solution for Advancing Epilepsy Research 2024-02-01
- PTZ-treated Zebrafish provide a high throughput platform for screening novel anti-epileptic drugs 2024-01-25
- Beyond Seizures: Epilepsy Comorbidities Explored in Mouse Kindling Studies 2024-01-18
- Novelty-suppressed feeding and novelty-induced hypophagia: exploring sex differences and response to diazepam in C57BL/6J mice. 2023-12-14
- Development & validation of intrathecal dosing in rats and mice 2023-12-05
- Transpharmation's Mouse-EEG capability reveals cross-species effects of novel antidepressants ketamine and psilocybin 2023-11-22
- Oral Health: Not just for Humans... 2023-10-31
- Accelerate Your Diabetes Drug Development with Transpharmation's Dog Diabetes Models 2023-10-18
- Introducing our new data analysis service for tremor-plate signals! 2023-09-29
- Introducing the Scn1a mutant mouse model of Dravet Syndrome at Transpharmation 2023-09-21
- New validated pre-clinical model to assess treatments for post-surgical pain 2023-08-31
- Experimental Autoimmune Encephalomyelitis; Modelling Multiple Sclerosis and Beyond 2023-08-21
- New Preclinical Models of Migraine for Assessment of Rescue and Preventive Analgesic Treatments 2023-08-01
- Do Your Compounds Exhibit Anti-Inflammatory Compounds 2023-07-17
- Profile your anti-inflammatory compounds in primary human immune cells 2023-06-28
- New EEG services from Transpharmation. Read on for results... 2023-06-14
- Accelerate your Drug Discovery Research. Proven results, fast and cost effective 2023-06-07
- Urgent Treatments Needed for Parkinson's Disease 2023-05-16
- Poor bioavailability, is the liver or intestine to blame? 2023-05-03
- Laser Doppler; new validated protocols revealed. 2023-04-21
- Epilepsy models leading the way. Read on for results. 2023-03-27
- Profiling anti-inflammatory drugs; from rodent to human 2023-03-02
- The Mismatch Negativity Challenge 2023-01-25
- Accelerate your drug discovery research. Proven science based results cost-effectively. 2022-12-20
- Anxiety. Three preclinical tests; data revealed... 2022-12-12
- Seven new posters, presented at SfN, now available to view. 2022-11-23
- Name change announcement! News from the CEO. 2022-11-04
- Chronic fatigue: different etiologies influence translational models 2022-10-18
- Seven new translational studies to share with you at this year's SfN event. Read on for poster titles and contact details. 2022-10-03
- Translational value increased with non-evoked pain measures. 2022-09-21
- Rapid access to PK non-rodent studies. Leading expertise. 2022-09-01
- Essential tremor research 2022-08-19
- Can a psychedelic experience be modelled in rats? 2022-08-01
- Gender Differences in Pain. New research revealed! 2022-06-30
- New data on the effect of single dose psilocybin! 2022-05-25
- From ketamine to psychedelics, join our webinar starting tomorrow! 2022-05-09
- Long term delayed effects of psychedelics in preclinical models. Trailblazing results revealed! 2022-04-05
- Accreditation awarded with flying colours 2022-03-01
- Breaking news! Merger announcement between Transpharmation and InterVivo Solutions. 2022-02-08
- Take a look! New posters, nine therapeutic areas available to view now. 2021-12-01
- Nine new compelling studies to be revealed at SfN21! 2021-11-03
- Can changes in EEG improve neuropathic pain treatments? 2021-10-11
- 40Hz ASSR: sounds that change our thoughts about schizophrenia 2021-08-31
- Clerkenwell Health and Transpharmation combine lab and human trials for psilocybin 2021-08-09
- Translational endpoints for preclinical pain - improving your chances. 2021-07-01
- Transpharmation aims for global standard. Let's talk about lab sustainability. 2021-06-02
- Targeting the unmet medical need in Parkinson's Disease - the fastest growing neurological disorder. 2021-04-15
- Psilocybin: the power of mental reorganisation 2020-12-06
- Expansion to world class premises 2020-11-04
- Multiple therapeutic indications 2020-10-05
- Focus on pain 2020-09-04
- Gene therapies for body and brain in Duchenne Muscular Dystrophy, progress moves forward. 2020-03-08
- Announcing Transpharmation Poland! 2020-02-08